Literature DB >> 25795791

High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children.

Masanori Terajima1, Mary Dawn T Co1, John Cruz1, Francis A Ennis1.   

Abstract

Human influenza is a highly contagious acute respiratory illness that is responsible for significant morbidity and excess mortality worldwide. In addition to neutralizing antibodies, there are antibodies that bind to influenza virus-infected cells and mediate lysis of the infected cells by natural killer (NK) cells (antibody-dependent cellular cytotoxicity [ADCC]) or complement (complement-dependent lysis [CDL]). We analyzed sera obtained from 16 healthy adults (18-63 years of age), 52 children (2-17 years of age), and 10 infants (0.75-1 year of age) in the United States, who were unlikely to have been exposed to the avian H7N9 subtype of influenza A virus, by ADCC and CDL assays. As expected, none of these sera had detectable levels of hemagglutination-inhibiting antibodies against the H7N9 virus, but we unexpectedly found high titers of ADCC antibodies to the H7N9 subtype virus in all sera from adults and children aged ≥8 years.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ADCC, complement-dependent lysis; H7N9 subtype; H5N1 subtype; antibody-dependent cell-mediated cytotoxicity; antibody-dependent cellular cytotoxicity; avian influenza viruses; hemagglutination-inhibition; non-neutralizing antibody

Mesh:

Substances:

Year:  2015        PMID: 25795791      PMCID: PMC4668882          DOI: 10.1093/infdis/jiv181

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells.

Authors:  P G Hughey; R W Compans; S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Influenza immunity: new insights from old studies.

Authors:  Edwin D Kilbourne
Journal:  J Infect Dis       Date:  2005-11-21       Impact factor: 5.226

3.  Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Authors:  Suzanne L Epstein
Journal:  J Infect Dis       Date:  2005-11-21       Impact factor: 5.226

4.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

Review 5.  A question of self-preservation: immunopathology in influenza virus infection.

Authors:  Nicole L La Gruta; Katherine Kedzierska; John Stambas; Peter C Doherty
Journal:  Immunol Cell Biol       Date:  2007-01-09       Impact factor: 5.126

6.  Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.

Authors:  R A Lamb; S L Zebedee; C D Richardson
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

7.  Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells.

Authors:  G Hashimoto; P F Wright; D T Karzon
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

8.  Antibody reactive in antibody-dependent cell-mediated cytotoxicity following influenza virus vaccination.

Authors:  S Vella; G Rocchi; S Resta; M Marcelli; A De Felici
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

Review 9.  Variation and infectivity neutralization in influenza.

Authors:  Marcel Knossow; John J Skehel
Journal:  Immunology       Date:  2006-09       Impact factor: 7.397

10.  Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.

Authors:  JingQi Feng; Manxin Zhang; Krystyna Mozdzanowska; Darya Zharikova; Henry Hoff; William Wunner; Robert B Couch; Walter Gerhard
Journal:  Virol J       Date:  2006-12-06       Impact factor: 4.099

View more
  29 in total

1.  Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.

Authors:  Sinthujan Jegaskanda; Catherine Luke; Heather D Hickman; Mark Y Sangster; Wendy F Wieland-Alter; Jacqueline M McBride; Jon W Yewdell; Peter F Wright; John Treanor; Carrie M Rosenberger; Kanta Subbarao
Journal:  J Infect Dis       Date:  2016-06-28       Impact factor: 5.226

2.  Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine.

Authors:  Anne B Kristensen; William N Lay; Fernanda Ana-Sosa-Batiz; Hillary A Vanderven; Vijaya Madhavi; Karen L Laurie; Louise Carolan; Bruce D Wines; Mark Hogarth; Adam K Wheatley; Stephen J Kent
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

3.  Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.

Authors:  Wenqian He; Gene S Tan; Caitlin E Mullarkey; Amanda J Lee; Mannie Man Wai Lam; Florian Krammer; Carole Henry; Patrick C Wilson; Ali A Ashkar; Peter Palese; Matthew S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

4.  Preexisting Antibody-Dependent Cellular Cytotoxicity-Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure.

Authors:  Sophie A Valkenburg; Yanyu Zhang; Ka Y Chan; Kathy Leung; Joseph T Wu; Leo L M Poon
Journal:  J Infect Dis       Date:  2016-08-04       Impact factor: 5.226

5.  Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination.

Authors:  Carolyn M Boudreau; Wen-Han Yu; Todd J Suscovich; H Keipp Talbot; Kathryn M Edwards; Galit Alter
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 6.  Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.

Authors:  Sinthujan Jegaskanda; Hillary A Vanderven; Adam K Wheatley; Stephen J Kent
Journal:  Hum Vaccin Immunother       Date:  2017-03-23       Impact factor: 3.452

7.  Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.

Authors:  Sinthujan Jegaskanda; Mary Dawn T Co; John Cruz; Kanta Subbarao; Francis A Ennis; Masanori Terajima
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

8.  Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.

Authors:  Chen S Tan; Joshua Ghofrani; Emma Geiger; Igor J Koralnik; Stephanie Jost
Journal:  J Acquir Immune Defic Syndr       Date:  2019-10-01       Impact factor: 3.731

Review 9.  Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?

Authors:  Karlynn E Neu; Carole J Henry Dunand; Patrick C Wilson
Journal:  Curr Opin Immunol       Date:  2016-06-03       Impact factor: 7.486

Review 10.  Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.

Authors:  Suzanne L Epstein
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.